National Health Investors (NHI) Rating Increased to Buy at Zacks Investment Research

National Health Investors (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Friday, November 10th. The brokerage presently has a $86.00 price objective on the real estate investment trust’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 9.75% from the stock’s previous close.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI has been the subject of a number of other research reports. BidaskClub downgraded National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Capital One Financial assumed coverage on National Health Investors in a report on Monday, October 23rd. They set an “equal weight” rating for the company. Mizuho reissued a “hold” rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of National Health Investors in a report on Sunday, September 17th. Finally, SunTrust Banks assumed coverage on National Health Investors in a report on Tuesday, October 10th. They set a “hold” rating and a $80.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $80.14.

National Health Investors (NHI) traded up $0.04 on Friday, hitting $78.36. The stock had a trading volume of 158,900 shares, compared to its average volume of 209,305. National Health Investors has a 12 month low of $68.75 and a 12 month high of $81.21. The company has a quick ratio of 12.72, a current ratio of 12.72 and a debt-to-equity ratio of 0.84. The firm has a market capitalization of $3,245.74, a P/E ratio of 15.00, a P/E/G ratio of 3.84 and a beta of 0.58.

A number of hedge funds have recently bought and sold shares of the stock. California Public Employees Retirement System raised its stake in National Health Investors by 8.0% in the third quarter. California Public Employees Retirement System now owns 87,839 shares of the real estate investment trust’s stock valued at $6,789,000 after purchasing an additional 6,539 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in National Health Investors in the third quarter valued at about $237,000. Asset Management One Co. Ltd. raised its stake in National Health Investors by 1.5% in the third quarter. Asset Management One Co. Ltd. now owns 113,008 shares of the real estate investment trust’s stock valued at $8,766,000 after purchasing an additional 1,650 shares in the last quarter. Allianz Asset Management GmbH raised its stake in National Health Investors by 57.8% in the third quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock valued at $30,514,000 after purchasing an additional 144,650 shares in the last quarter. Finally, OxFORD Asset Management LLP raised its stake in National Health Investors by 95.2% in the third quarter. OxFORD Asset Management LLP now owns 22,342 shares of the real estate investment trust’s stock valued at $1,727,000 after purchasing an additional 10,897 shares in the last quarter. 70.65% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “National Health Investors (NHI) Rating Increased to Buy at Zacks Investment Research” was first published by BBNS and is owned by of BBNS. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://baseballnewssource.com/markets/national-health-investors-inc-nhi-upgraded-to-buy-by-zacks-investment-research/1775176.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.